Abstract:Persistent Mullerian Duct Syndrome (PMDS) is a rare congenital disorder in males, characterized by the presence of Mullerian duct derivatives despite normal testes and external genitalia. This condition is typically linked to a dysfunction in the anti-Mullerian hormone (AMH) or its receptor (AMHR2), both of which are critical for the regression of the Mullerian ducts. In dogs, PMDS is particularly frequent in the Miniature Schnauzer breed, although cases have also been reported in other breeds, such as the Yorkshire Terrier. To date, a single causative variant has been identified in the AMHR2 gene, but only in Miniature Schnauzers. No deleterious variants have been found in the AMH gene; however, with the exception of one report, most studies have not sequenced the entire exon 5. This study provides novel insights into the genomic organization of canine AMH and AMHR2 genes through bioinformatics and in silico analyses of previously reported whole-genome sequencing (WGS) data from a Yorkshire Terrier affected by PMDS. The results indicate that current canine genome assemblies (ROS_Cfam_1.0; CanFam4, and CanFam6) contain a complete reference sequence for the AMH gene, unlike the earlier CanFam3.1 genome. However, next-generation sequencing technologies (WGS and RNA-seq) face challenges due to technical limitations in analyzing GC-rich repetitive elements present in exon 5 of canine AMH gene. In contrast, the genomic structure of the AMHR2 gene remains inaccurately represented in the current ROS_Cfam_1.0 genome (eight instead of eleven exons), while both CanFam4 and CanFam6 contain additional and unknown nucleotide/amino acid sequences. The CanFam3.1 genome assembly still provides the most accurate annotation for canine AMHR2 gene. Based on these findings, re-sequencing of the AMH gene in previously reported dogs affected by PMDS using the methodology proposed in recent literature is recommended. Further attention should be given to comparative analyses to assess whether the canine genome contains accurate information about genes or proteins that correspond to human orthologs.

Current Classification of Canine Muscular Dystrophies and Identification of New Variants

Research Progress on Disease Models and Gene Therapy of Duchenne Muscular Dystrophy

Expanding the Molecular Genetic Landscape of Dystrophinopathies and Associated Phenotypes

Exonisation of an intronic L1 element in the dystrophin gene associated with X‐linked muscular dystrophy in a Border Collie dog

Genetic Variation Analysis and Treatment Strategy of 20 Patients with Dystrophin Gene Mutations

DMD Mutations in 576 Dystrophinopathy Families: A Step Forward in Genotype-Phenotype Correlations

Novel COL5A1 variants and associated disease phenotypes in dogs with classical Ehlers-Danlos syndrome

Multi-Allelic Mitochondrial DNA Deletions in an Adult Dog with Chronic Weakness, Exercise Intolerance and Lactic Acidemia

Intragenic dystrophin (DMD) duplication variant in Entlebucher Mountain Dogs with Duchenne muscular dystrophy

Persistent Mullerian duct syndrome in dogs: a new insight into organization of AMH and AMHR2 genes

The sensitivity of exome sequencing in identifying pathogenic mutations for LGMD in the United States

Genetic and Clinical Advances of Congenital Muscular Dystrophy.

A comparative study of N-glycolylneuraminic acid (Neu5Gc) and cytotoxic T cell (CT) carbohydrate expression in normal and dystrophin-deficient dog and human skeletal muscle

Complex disease and phenotype mapping in the domestic dog

Current advance on distal myopathy genetics

Longitudinal assessment of skeletal muscle functional mechanics in the DE50-MD dog model of Duchenne muscular dystrophy

Genetic Dystonias: Update on Classification and New Genetic Discoveries

Gene-expression profiling of endomyocardial biopsies from dogs with dilated cardiomyopathy phenotype

The complex landscape of DMD mutations: moving towards personalized medicine

DMD deletions underlining mild dystrophinopathies: literature review highlights phenotype-related mutation clusters and provides insights about genetic mechanisms and prognosis

Advancing Biomarker Discovery and Therapeutic Targets in Duchenne Muscular Dystrophy: A Comprehensive Review